Back to Search
Start Over
Supplementary Table 3 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Adverse events
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....52397cae5f9e323204a143cd7e6f50f3
- Full Text :
- https://doi.org/10.1158/1078-0432.22471170